Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

Orazio Fortunato, Cristina Borzi, Massimo Milione, Giovanni Centonze, Davide Conte, Mattia Boeri, Carla Verri, Massimo Moro, Federica Facchinetti, Francesca Andriani, Luca Roz, Laura Caleca, Veronica Huber, Agata Cova, Chiara Camisaschi, Chiara Castelli, Valeria Cancila, Claudio Tripodo, Ugo Pastorino, Gabriella Sozzi

Research output: Contribution to journalArticle

Abstract

miRNAs play a central role in the complex signaling network of cancer cells with the tumor microenvironment. Little is known on the origin of circulating miRNAs and their relationship with the tumor microenvironment in lung cancer. Here, we focused on the cellular source and relative contribution of different cell types to circulating miRNAs composing our risk classifier of lung cancer using in vitro/in vivo models and clinical samples. A cell-type specific expression pattern and topography of several miRNAs such as mir-145 in fibroblasts, mir-126 in endothelial cells, mir-133a in skeletal muscle cells was observed in normal and lung cancer tissues. Granulocytes and platelets are the major contributors of miRNAs release in blood. miRNAs modulation observed in plasma of lung cancer subjects was consistent with de-regulation of the same miRNAs observed during immunosuppressive conversion of immune cells. In particular, activated neutrophils showed a miRNA profile mirroring that observed in plasma of lung cancer subjects. Interestingly mir-320a secreted by neutrophils of high-risk heavy-smokers promoted an M2-like protumorigenic phenotype through downregulation of STAT4 when shuttled into macrophages. These findings suggest a multifactorial and nonepithelial cell-autonomous origin of circulating miRNAs associated with risk of lung cancer and that circulating miRNAs may act in paracrine signaling with causative role in lung carcinogenesis and immunosuppression.

Original languageEnglish
Pages (from-to)2746-2761
Number of pages16
JournalInternational Journal of Cancer
Volume144
Issue number11
DOIs
Publication statusPublished - Jun 1 2019

Fingerprint

Immunosuppressive Agents
MicroRNAs
Lung Neoplasms
Macrophages
Phenotype
Tumor Microenvironment
Neutrophils
Paracrine Communication
Granulocytes
Immunosuppression
Muscle Cells
Carcinogenesis
Skeletal Muscle
Blood Platelets
Down-Regulation
Endothelial Cells
Fibroblasts
Lung

Keywords

  • lung cancer
  • microenvironment
  • microRNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk. / Fortunato, Orazio; Borzi, Cristina; Milione, Massimo; Centonze, Giovanni; Conte, Davide; Boeri, Mattia; Verri, Carla; Moro, Massimo; Facchinetti, Federica; Andriani, Francesca; Roz, Luca; Caleca, Laura; Huber, Veronica; Cova, Agata; Camisaschi, Chiara; Castelli, Chiara; Cancila, Valeria; Tripodo, Claudio; Pastorino, Ugo; Sozzi, Gabriella.

In: International Journal of Cancer, Vol. 144, No. 11, 01.06.2019, p. 2746-2761.

Research output: Contribution to journalArticle

Fortunato, Orazio ; Borzi, Cristina ; Milione, Massimo ; Centonze, Giovanni ; Conte, Davide ; Boeri, Mattia ; Verri, Carla ; Moro, Massimo ; Facchinetti, Federica ; Andriani, Francesca ; Roz, Luca ; Caleca, Laura ; Huber, Veronica ; Cova, Agata ; Camisaschi, Chiara ; Castelli, Chiara ; Cancila, Valeria ; Tripodo, Claudio ; Pastorino, Ugo ; Sozzi, Gabriella. / Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk. In: International Journal of Cancer. 2019 ; Vol. 144, No. 11. pp. 2746-2761.
@article{b9ba0e289afc44bcbfd10156337b7ed5,
title = "Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk",
abstract = "miRNAs play a central role in the complex signaling network of cancer cells with the tumor microenvironment. Little is known on the origin of circulating miRNAs and their relationship with the tumor microenvironment in lung cancer. Here, we focused on the cellular source and relative contribution of different cell types to circulating miRNAs composing our risk classifier of lung cancer using in vitro/in vivo models and clinical samples. A cell-type specific expression pattern and topography of several miRNAs such as mir-145 in fibroblasts, mir-126 in endothelial cells, mir-133a in skeletal muscle cells was observed in normal and lung cancer tissues. Granulocytes and platelets are the major contributors of miRNAs release in blood. miRNAs modulation observed in plasma of lung cancer subjects was consistent with de-regulation of the same miRNAs observed during immunosuppressive conversion of immune cells. In particular, activated neutrophils showed a miRNA profile mirroring that observed in plasma of lung cancer subjects. Interestingly mir-320a secreted by neutrophils of high-risk heavy-smokers promoted an M2-like protumorigenic phenotype through downregulation of STAT4 when shuttled into macrophages. These findings suggest a multifactorial and nonepithelial cell-autonomous origin of circulating miRNAs associated with risk of lung cancer and that circulating miRNAs may act in paracrine signaling with causative role in lung carcinogenesis and immunosuppression.",
keywords = "lung cancer, microenvironment, microRNA",
author = "Orazio Fortunato and Cristina Borzi and Massimo Milione and Giovanni Centonze and Davide Conte and Mattia Boeri and Carla Verri and Massimo Moro and Federica Facchinetti and Francesca Andriani and Luca Roz and Laura Caleca and Veronica Huber and Agata Cova and Chiara Camisaschi and Chiara Castelli and Valeria Cancila and Claudio Tripodo and Ugo Pastorino and Gabriella Sozzi",
year = "2019",
month = "6",
day = "1",
doi = "10.1002/ijc.31988",
language = "English",
volume = "144",
pages = "2746--2761",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

AU - Fortunato, Orazio

AU - Borzi, Cristina

AU - Milione, Massimo

AU - Centonze, Giovanni

AU - Conte, Davide

AU - Boeri, Mattia

AU - Verri, Carla

AU - Moro, Massimo

AU - Facchinetti, Federica

AU - Andriani, Francesca

AU - Roz, Luca

AU - Caleca, Laura

AU - Huber, Veronica

AU - Cova, Agata

AU - Camisaschi, Chiara

AU - Castelli, Chiara

AU - Cancila, Valeria

AU - Tripodo, Claudio

AU - Pastorino, Ugo

AU - Sozzi, Gabriella

PY - 2019/6/1

Y1 - 2019/6/1

N2 - miRNAs play a central role in the complex signaling network of cancer cells with the tumor microenvironment. Little is known on the origin of circulating miRNAs and their relationship with the tumor microenvironment in lung cancer. Here, we focused on the cellular source and relative contribution of different cell types to circulating miRNAs composing our risk classifier of lung cancer using in vitro/in vivo models and clinical samples. A cell-type specific expression pattern and topography of several miRNAs such as mir-145 in fibroblasts, mir-126 in endothelial cells, mir-133a in skeletal muscle cells was observed in normal and lung cancer tissues. Granulocytes and platelets are the major contributors of miRNAs release in blood. miRNAs modulation observed in plasma of lung cancer subjects was consistent with de-regulation of the same miRNAs observed during immunosuppressive conversion of immune cells. In particular, activated neutrophils showed a miRNA profile mirroring that observed in plasma of lung cancer subjects. Interestingly mir-320a secreted by neutrophils of high-risk heavy-smokers promoted an M2-like protumorigenic phenotype through downregulation of STAT4 when shuttled into macrophages. These findings suggest a multifactorial and nonepithelial cell-autonomous origin of circulating miRNAs associated with risk of lung cancer and that circulating miRNAs may act in paracrine signaling with causative role in lung carcinogenesis and immunosuppression.

AB - miRNAs play a central role in the complex signaling network of cancer cells with the tumor microenvironment. Little is known on the origin of circulating miRNAs and their relationship with the tumor microenvironment in lung cancer. Here, we focused on the cellular source and relative contribution of different cell types to circulating miRNAs composing our risk classifier of lung cancer using in vitro/in vivo models and clinical samples. A cell-type specific expression pattern and topography of several miRNAs such as mir-145 in fibroblasts, mir-126 in endothelial cells, mir-133a in skeletal muscle cells was observed in normal and lung cancer tissues. Granulocytes and platelets are the major contributors of miRNAs release in blood. miRNAs modulation observed in plasma of lung cancer subjects was consistent with de-regulation of the same miRNAs observed during immunosuppressive conversion of immune cells. In particular, activated neutrophils showed a miRNA profile mirroring that observed in plasma of lung cancer subjects. Interestingly mir-320a secreted by neutrophils of high-risk heavy-smokers promoted an M2-like protumorigenic phenotype through downregulation of STAT4 when shuttled into macrophages. These findings suggest a multifactorial and nonepithelial cell-autonomous origin of circulating miRNAs associated with risk of lung cancer and that circulating miRNAs may act in paracrine signaling with causative role in lung carcinogenesis and immunosuppression.

KW - lung cancer

KW - microenvironment

KW - microRNA

UR - http://www.scopus.com/inward/record.url?scp=85059570892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059570892&partnerID=8YFLogxK

U2 - 10.1002/ijc.31988

DO - 10.1002/ijc.31988

M3 - Article

C2 - 30426475

AN - SCOPUS:85059570892

VL - 144

SP - 2746

EP - 2761

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 11

ER -